Cameron D Thomas

Cameron D Thomas,

Postdoctoral Associate

Department: Pharmacotherapy & Translational Research
Business Phone: (352) 273-6446
Business Email: camerondthomas@cop.ufl.edu

Publications

2021
A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management.
Genetics in medicine : official journal of the American College of Medical Genetics. 23(4):621-628 [DOI] 10.1038/s41436-020-01050-4. [PMID] 33420349.
2021
Impact of the CYP2C19*17 Allele on Outcomes in Patients Receiving Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.
Clinical pharmacology and therapeutics. 109(3):705-715 [DOI] 10.1002/cpt.2039. [PMID] 32897581.
2020
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing.
Clinical pharmacology and therapeutics. [DOI] 10.1002/cpt.2015. [PMID] 32770672.
2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
CPT: pharmacometrics & systems pharmacology. 9(12):678-685 [DOI] 10.1002/psp4.12563. [PMID] 33067866.
2020
Pharmacogenetic factors affecting β-blocker metabolism and response.
Expert opinion on drug metabolism & toxicology. 16(10):953-964 [DOI] 10.1080/17425255.2020.1803279. [PMID] 32726152.
2019
Evaluation of the protective effects of β-blockers in the management of acute exacerbations of chronic obstructive pulmonary disease.
Journal of clinical pharmacy and therapeutics. 44(1):109-114 [DOI] 10.1111/jcpt.12767. [PMID] 30311242.

Contact Details

Phones:
Business:
(352) 273-6446
Emails: